CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹3,481 Cr | ₹3,134 Cr | ₹2,563 Cr | ₹1,507 Cr | ₹1,031 Cr |
What is the latest Short Term Loans and Advances ratio of CIPLA ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹3,481 Cr |
| Mar2024 | ₹3,134 Cr |
| Mar2023 | ₹2,563 Cr |
| Mar2022 | ₹1,507 Cr |
| Mar2021 | ₹1,031 Cr |
How is Short Term Loans and Advances of CIPLA Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,481 Cr | 11.08 | |
| Mar2024 | ₹3,134 Cr | 22.28 | |
| Mar2023 | ₹2,563 Cr | 70.07 | |
| Mar2022 | ₹1,507 Cr | 46.18 | |
| Mar2021 | ₹1,031 Cr | - | |
Compare Short Term Loans and Advances of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹105,813.7 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| MANKIND PHARMA | ₹92,744.0 Cr | -0.9% | 10.1% | -11.6% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.2% |
5.4% |
-13.7% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses